-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-18
The reference study used voltage-clamped frog nerve fibers to compare Halazone and related chemical reagents as probes of sodium-current inactivation. Its contrasting reagent responses weakened the case for a uniquely essential methionine residue and instead supported a cautious membrane-lipid explanation, while also defining important limits for translating neurophysiological findings to water disinfection or antimicrobial resistance research.
-
EZ Cap™ Cy5 EGFP mRNA: A Two-Clock Assay
2026-08-18
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates cellular uptake from productive translation through Cy5 and EGFP signals. This article presents a morphology-aware framework for interpreting mRNA delivery data and designing more decisive gene regulation studies.
-
Nintedanib: An ATRX-Aware Research Framework
2026-08-17
Nintedanib (BIBF 1120) offers a powerful way to study coordinated VEGFR, FGFR, and PDGFR signaling. This article presents an ATRX-aware assay framework that separates direct tumor-cell vulnerability from vascular and stromal effects.
-
β-Elemene Inhibits Adipogenesis via AMPK
2026-08-17
The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 cells and connects this effect with restoration of AMPK-pathway activity. Its in vitro design provides a useful framework for examining lipid accumulation, insulin resistance, glucose handling, and signaling responses, while leaving in vivo efficacy and molecular target validation for future work.
-
Anti Reverse Cap Analog for Synthetic mRNA
2026-08-16
Learn how orientation-specific 5′ capping can improve synthetic mRNA translation, from in vitro transcription setup to cell-reprogramming workflows. Practical parameters, assay choices, and troubleshooting guidance connect ARCA chemistry with transgene-free oligodendrocyte differentiation research.
-
AI-10-49 Workflow for CBFβ-SMMHC Inhibition
2026-08-15
AI-10-49 connects direct CBFβ-SMMHC–RUNX1 dissociation with chromatin, transcriptional, viability, and animal-model readouts. This mechanism-led workflow helps distinguish selective target engagement from nonspecific leukemia cell toxicity in acute myeloid leukemia research.
-
Recombinant Human Oncostatin M: Assay Workflows
2026-08-14
Build more reproducible cytokine stimulation, proliferation, and release assays with tag-free, E. coli–expressed rh-Oncostatin M. This guide translates findings on CXCL1-CXCR2-driven neuroinflammation into practical, hypothesis-generating assay designs without conflating OSM biology with the reference pathway.
-
SB-3CT Workflows for MMP-9 and ECM Assays
2026-08-14
SB-3CT is a mechanism-based gelatinase inhibitor for separating MMP-2 and MMP-9 activity in extracellular-matrix, tumor, and neural models. This workflow-focused guide covers dosing logic, PNN assay design, matrix handling, and troubleshooting for reproducible preclinical experiments.
-
Dabigatran Etexilate: From Prodrug to Assay
2026-08-13
Dabigatran etexilate is an oral prodrug and direct thrombin inhibitor with important implications for translational coagulation research. This guide focuses on how prodrug activation, assay selection, and matrix choice shape interpretable thrombin-inhibition data.
-
AZD3463 Workflow for ALK-Driven Cancer Research
2026-08-13
Build reproducible neuroblastoma experiments around AZD3463, from ALK genotype-aware dosing to pathway and combination readouts. The workflow pairs defined assay design with practical handling, troubleshooting, and translational planning for an ALK/IGF1R inhibitor.
-
CX-5461 Drives Mitotic Catastrophe in Cervical Cancer
2026-08-12
The reference study shows that CX-5461 suppresses cervical cancer cell growth through a mechanistic sequence linking RNA polymerase I inhibition to ATM/ATR-associated DNA damage, abnormal mitotic entry, and mitotic catastrophe. It also reports increased cisplatin sensitivity, providing a rationale for investigating Pol I inhibition in treatment-resistant cervical cancer models.
-
MK-4827 (Niraparib) in DNA Repair Research
2026-08-12
MK-4827 (Niraparib) enables controlled PARP-1/-2 inhibition for BRCA-mutant models, radiosensitization studies, and emerging spliceosome–DNA repair research in hepatocellular carcinoma. This guide translates its biochemical profile into practical dosing, combination, readout, and troubleshooting workflows.
-
Stiripentol: Reliable LDH Inhibition in Cell Assays
2026-08-11
Learn how Stiripentol (SKU A8704) can support controlled LDH and lactate-pathway perturbation in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, stock preparation, interpretation, cross-domain limitations, and practical supplier selection.
-
Targeted mRNA Nanoparticles Repair the Poststroke BBB
2026-08-11
Gao and colleagues developed mannose receptor-targeting lipid nanoparticles that deliver IL-10 mRNA to ischemic brain regions and reinforce protective microglial polarization. In mouse stroke models, this pathology-responsive approach reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and supported functional recovery, including treatment initiated up to 72 h after stroke.
-
Prestained Protein Marker for UV Stress Assays
2026-08-10
Use a defined Triple color protein ladder to track electrophoresis, confirm transfer, and improve confidence in UV-stress immunoblots. Its EDTA-free formulation extends the workflow to Phosbind gels and fluorescent membrane imaging without heat incubation or added loading buffer.